Innoviva, Inc. reports

Company location: Burlingame, CA
Fiscal year end: 31 December

Innoviva, Inc. has filed 1,661 SEC EDGAR filings since 21 Mar 2000

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page

25

Current page

36

4

FORM 4 -

Filing date: 22 Nov 2013
Reporting date: 20 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Nov 2013
Reporting date: 20 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 18 Nov 2013
Reporting date: 18 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 13 Nov 2013
Reporting date: 13 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 13 Nov 2013
Reporting date: 13 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 12 Nov 2013
Reporting date: 12 Nov 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-30319

10-Q

Filing date: 01 Nov 2013
Reporting date: 30 Sep 2013
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 30 Oct 2013
Reporting date: 30 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 29 Oct 2013
Reporting date: 29 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Oct 2013
Reporting date: 22 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 -

Filing date: 24 Oct 2013
Reporting date: 14 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 24 Oct 2013
Reporting date: 24 Oct 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 20 Sep 2013
Reporting date: 20 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 19 Sep 2013
Reporting date: 19 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 13 Sep 2013
Reporting date: 12 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 10 Sep 2013
Reporting date: 10 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 10 Sep 2013
Reporting date: 10 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 09 Sep 2013
Reporting date: 08 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE INC. 8-K

Filing date: 06 Sep 2013
Reporting date: 06 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

8-K

Filing date: 05 Sep 2013
Reporting date: 05 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-30319

THERAVANCE, INC. 8-K

Filing date: 04 Sep 2013
Reporting date: 04 Sep 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Aug 2013
Reporting date: 20 Aug 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Aug 2013
Reporting date: 20 Aug 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Aug 2013
Reporting date: 20 Aug 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Aug 2013
Reporting date: 20 Aug 2013
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .